Web Date: January 10, 2017
Perlara signs pacts with Grace Science and Wylder Nation Foundation
Building on its unusual business model, Perlara has secured its first two deals with patient advocacy groups looking to directly fund discovery of drugs for rare diseases. Grace Science Foundation, focused on finding a cure for Ngly1 deficiency, and the Wylder Nation Foundation, which seeks treatments for acid sphingomyelinase deficiency (ASD), will both back early-stage research at the biotech firm.
Each family-run group has signed up for what Perlara calls a PerlQuest, a tailored research . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society